167 related articles for article (PubMed ID: 56409)
1. Antibodies specific to isoniazid and isonicotinic acid.
Tse KS; Vijay H; Attallah N; Sehon AH
J Immunol; 1976 Apr; 116(4):965-9. PubMed ID: 56409
[TBL] [Abstract][Full Text] [Related]
2. Detection of IgE antibodies specific to isonicotinic acid hydrazide and its metabolite by enzyme-linked immunosorbent assay and the mechanism of sensitization by inhalation or ingestion of this compound.
Shimoda T
Arerugi; 1990 Jul; 39(7):567-76. PubMed ID: 2073137
[TBL] [Abstract][Full Text] [Related]
3. Studies on the induction of antibody synthesis against sulfanilic acid in rabbits. I. Effect of the number of hapten molecules introduced in homologous protein on antibody synthesis against the hapten and the new antigenic determinants.
Rubin B
Eur J Immunol; 1972 Feb; 2(1):5-11. PubMed ID: 4117184
[No Abstract] [Full Text] [Related]
4. The immune response against hapten-autologous protein conjugates in the mouse. I. Specificity of antibodies produced during the primary response against dinitrophenylated mouse serum albumin.
Rubin B
Eur J Immunol; 1973 Jan; 3(1):26-32. PubMed ID: 4123957
[No Abstract] [Full Text] [Related]
5. Studies on the immune response in chickens. III. Effect of substitution of carrier on elicitation of anti-hapten antibody responses and generation of hapten-specific memory.
Nagase F; Nakashima I; Kato N
Immunology; 1979 Jun; 37(2):339-44. PubMed ID: 89081
[TBL] [Abstract][Full Text] [Related]
6. Effect of carrier priming on the distribution of anti-hapten antibodies between IgG1 and IgG2 isotypes in the hyperimmune guinea pig.
Liu SH; Koo PH; Cebra JJ
J Immunol; 1974 Aug; 113(2):677-87. PubMed ID: 4136042
[No Abstract] [Full Text] [Related]
7. Reaginic antibody formation in the mouse. 3. Collaboration between hapten-specific memory cells and carrier-specific helper cells for secondary anti-hapten antibody formation.
Okudaira H; Ishizaka K
J Immunol; 1973 Nov; 111(5):1420-8. PubMed ID: 4126773
[No Abstract] [Full Text] [Related]
8. Synthesis and characterization of hapten-protein conjugates for antibody production against small molecules.
Singh KV; Kaur J; Varshney GC; Raje M; Suri CR
Bioconjug Chem; 2004; 15(1):168-73. PubMed ID: 14733597
[TBL] [Abstract][Full Text] [Related]
9. Induction of antibodies to nuclear antigens in rabbits by immunization with hydralazine-human serum albumin conjugates.
Yamauchi Y; Litwin A; Adams L; Zimmer H; Hess EV
J Clin Invest; 1975 Oct; 56(4):958-69. PubMed ID: 808562
[TBL] [Abstract][Full Text] [Related]
10. Suppression of reaginic antibody formation. III. Relationship between immunogenecity and tolerogenicity of hapten-carrier conjugates.
Lee WY; Sehon AH
J Immunol; 1976 Jun; 116(6):1711-8. PubMed ID: 58048
[TBL] [Abstract][Full Text] [Related]
11. Immunochemistry of conjugates prepared from serum albumins and acridine nitrogen mustards (ICR mutagens).
Creech HJ; O'Connell AP
Cancer Res; 1981 Oct; 41(10):3844-51. PubMed ID: 7284992
[TBL] [Abstract][Full Text] [Related]
12. Antibody production: Low dose immunogen vs. low incorporation hapten using salmeterol as a model.
Fodey TL; Greer NM; Crooks SR
Anal Chim Acta; 2009 Apr; 637(1-2):328-32. PubMed ID: 19286047
[TBL] [Abstract][Full Text] [Related]
13. Studies on the immunogenicity of antigen-antibody precipitates. II. The suppressive effect of anti-carrier and anti-hapten antibodies on the immunogenicity of dinitrophenylated human gamma G globulin.
Henney CS; Ishizaka K
J Immunol; 1970 Jun; 104(6):1540-9. PubMed ID: 4195052
[No Abstract] [Full Text] [Related]
14. T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.
Shimizu T; Osaka Y; Banri-Koike C; Yoshida M; Endo K; Furukawa K; Oda M; Murakami A; Ogawa S; Abe R; Azuma T
Int Immunol; 2007 Oct; 19(10):1157-64. PubMed ID: 17881502
[TBL] [Abstract][Full Text] [Related]
15. [Study of a fraction antigenically unrelated to the immunoglobulins obtained by immunoadsorption from anti-hapten or anti-protein rabbit sera (author's transl)].
Escribano MJ
Ann Immunol (Paris); 1978; 129(2-3):233-44. PubMed ID: 79327
[TBL] [Abstract][Full Text] [Related]
16. The technical problems shoot for the production of anti low molecular weight hapten antibody.
Watanabe T; Nakasaki H; Kamijou A; Mitomi T; Matsuki H; Kasuga H
Kitasato Arch Exp Med; 1993 Apr; 65 Suppl():47-55. PubMed ID: 7967380
[TBL] [Abstract][Full Text] [Related]
17. Acetaldehyde-albumin adduct formation: possible relevance to an immunologic mechanism in alcoholism.
Fleisher JH; Lung CC; Meinke GC; Pinnas JL
Alcohol Alcohol; 1988; 23(2):133-41. PubMed ID: 3390237
[TBL] [Abstract][Full Text] [Related]
18. Studies on the dimensions of the rabbit antibenzylpenicilloyl antibody-combing sites.
LEVINE BB
J Exp Med; 1963 Jan; 117(1):161-83. PubMed ID: 13930142
[TBL] [Abstract][Full Text] [Related]
19. The sheep immune response. Variation of anti-hapten and anti-carrier antibodies in the 1 and 2 immunoglobulin fractions.
Margni RA; Castrelos OD; Paz CB
Immunology; 1973 May; 24(5):781-9. PubMed ID: 4123676
[TBL] [Abstract][Full Text] [Related]
20. Requirements for inducing tolerance of hapten-specific delayed hypersensitivity: epitope density.
Moon MM; Redelman D; Wolvos TA; Bauer DC
J Immunol; 1977 Dec; 119(6):2005-12. PubMed ID: 72114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
